Via CIDRAP, Lisa Schnirring writes: Study profiles US threat from drug-resistant bacteria. Excerpt:
In the clearest picture yet of the burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States—an important cause of healthcare-associated infections—a group from the Centers for Disease Control and Prevention (CDC) yesterday reported low overall incidence but regional variation, with most cases linked to earlier hospitalization and discharge to long-term care.
In 2013, the CDC sounded an alarm about CRE, thought to be more dangerous than methicillin-resistant Staphylococcus aureus (MRSA). CRE are resistant to nearly all antibiotics, have high mortality rates in invasive infections, and can spread their resistance genes to other bacteria in the body.
Echoing the CDC's 2013 warning, the researchers who published the latest surveillance findings say the low levels suggest the time is now to take action. The findings appeared yesterday in an early online edition of the Journal of the American Medical Association (JAMA).